Related Experiment Video
Updated: Aug 16, 2026

11:36
Cutaneous Leishmaniasis in the Dorsal Skin of Hamsters: a Useful Model for the Screening of Antileishmanial Drugs
Published on: April 21, 2012
Cutaneous leishmaniasis in Al-Badarna: a prospective study among school children
A A el-Buni1, A L Ben-Darif, I Taleb
1Medical Microbiology and Parasitology Department, Faculty of Medicine, Al-Arab Medical University, Benghazi, Libya.
Archives De L'Institut Pasteur De Tunis
|January 16, 2004
Abstract:
This paper presents the results of a prospective study cutaneous liashmaniasis in 2 schools in Al-Badarna, during the period from July to December 1992. The pupils were interviewed and examined. Positive cases were referred to the Health Unit for treatment. Of 260 pupils 22 (8.46%) were found to be infected with active lesions.
Related Concept Videos
Leishmaniasis
Leishmaniasis is a protozoal disease caused by species of the genus Leishmania and transmitted through the bite of infected female sandflies. The parasite exists in two principal morphological forms during its life cycle. A sandfly acquires intracellular amastigotes from an infected reservoir host, such as a dog. Within the sandfly, these forms differentiate into motile, flagellated promastigotes. During a subsequent blood meal, promastigotes are injected into the human host, where they...
Antiprotozoal Agents
Leishmaniasis is a widespread parasitic disease caused by several Leishmania species. It affects millions of people each year and remains a major public health problem in endemic regions. First-line treatment relies on pentavalent antimonials, including meglumine antimoniate and sodium stibogluconate. Even so, how these drugs work has not been fully clear, especially their interaction with parasite-specific biochemical pathways. One key target is trypanothione reductase (TR), an enzyme that...

